As the world's largest natural health expo, the NATURAL PRODUCTS EXPO WEST has a history of 37 years. It is rated as one of the top 100 exhibitions in terms of scale and influence in the United States and one of the top 50 fastest growing exhibitions. It brings together natural, healthy and organic products from around the world.
2025 Natural Products Expo West
Exhibition date: March 4, 2025-March 8, 2025
Holding address: Anaheim Convention Center, Los Angeles, USA
Exhibition industry: Natural food and ingredients
Organizer: American Organic Food Association, American International Exchange Group
Holding cycle: 1 year 1 exhibition
area: 70012.00㎡
Number of exhibitors: 3457
Number of visitors: 78731 people
As a pioneer in the field of oriental herbs, Qingyunshan Pharmaceutical participated in this event and demonstrated its innovative achievements in health and nutrition trends.
At this exhibition, we demonstrated the profound heritage and modern applications of oriental herbs to the visiting brands and cooperative enterprises, and concentrated on displaying a series of products under the framework of oriental herbs, including popular raw materials, plant extracts, functional foods, etc. The development of these products stems from our deep understanding of nature and health, and our keen insight and active response to global health trends.
Star Finished Product Series
AKK Series
AKK bacteria is the abbreviation of Akkermansia muciniphila, which was isolated from healthy human feces by Professor Willem M. de Vos' team in 2004. AKK bacteria account for 1~5% of the human microbial community and are resident bacteria in the human intestine. They colonize in the intestinal mucus layer and use intestinal mucin as food. The abundance of AKK bacteria in the intestine is related to the host's age, diet and health status, and its abundance is generally low in the Chinese population. A large number of studies have shown that AKK bacteria have significant effects in regulating intestinal barriers, weight management, lowering blood sugar, and anti-aging, and inactivated AKK bacteria have the same biological effects as live bacteria, or even better than live bacteria. The AKK series of finished products produced by Qingyunshan Pharmaceuticals has a new generation of probiotics AKK AM06™ strains with independent intellectual property rights
The AKK series of strains has the following advantages
Main products
Star raw material series---Berberine series
Berberine, also known as berberine, is a quaternary ammonium alkaloid isolated from the traditional Chinese medicine Coptis chinensis and is the main active ingredient in Coptis chinensis antibacterial. It is a yellow needle-shaped crystal with a bitter taste. Berberine has antibacterial effects on hemolytic streptococci, Staphylococcus aureus, gonococci, and Freund's and Shigella dysenteriae, and enhances the phagocytic effect of leukocytes. In addition, berberine also has the effect of regulating blood lipids and treating diabetes.
Berberine hydrochloride is an organic compound with a chemical formula of C20H18ClNO4. It is a yellow crystalline powder, easily soluble in boiling water, slightly soluble in cold water, and almost insoluble in cold ethanol, chloroform and ether. It is mainly used as an antibacterial drug. Antibacterial effect: berberine hydrochloride can inhibit bacterial sugar metabolism. Bacteria need energy to survive and reproduce, and sugar metabolism is an important way for them to obtain energy. Berberine hydrochloride is like an "energy blocker", interfering with the sugar metabolism process of bacteria, so that bacteria cannot get enough energy supply, thereby inhibiting their growth and reproduction. In addition, it can also interfere with the synthesis of bacterial DNA, prevent bacterial replication from the genetic material level, and further reduce the pathogenicity of bacteria.
Berberine is an isoquinoline alkaloid extracted from the dried rhizome ofCoptis chinensis French. Berberine can treat hyperlipidaemia, T2DM and fatty liver bymodulating various pathways and receptors, improve cardiovascular health, reduce body weight and prolongcellularlife. Berberine has poor solubility and low bioavailability in vivo. The metabolic form of berberine in the body is its interaction with the gutmicrobiota after oral administration. Nitroreductase (NR) in intestinal bacteria convertsberberine in the intestine into the easily absorbed form - dihydroberberine, which is5-10 times more absorbed than berberine in the intestine. metalions, etc,, causing dihydroberberine to quickly oxidize and convert back to berberine, and enter the bloodstream to exert its pharmacological effects. Dihvdroberberine can significantly improve gastrointestinal discomfowith lowerdoses and betterabsorotion compared to berberine
